Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tor Hervig

Showing results (11-20 of 118) with videos related to

Pageof 12
Sort By:
British Journal of Haematology|January 17, 2023
The 'scintilla' starting vaso-occlusion in sickle cell diseaseAndrea Piccin, Ibrahim Magzoub, Tor Hervig
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 8, 2013
Anemia treatment of lymphoproliferative malignancies with erypoiesis: an overview of state of the artDaniel Limi Cacic, Tor Hervig, Jerard Seghatchian
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 26, 2011
Effect of pathogen inactivation on the storage lesion in red cells and platelet concentratesJerard Seghatchian, Tor Hervig, Jeffrey S Putter
Blood Reviews|February 15, 2011
Current practice and future directions for optimization of platelet transfusions in patients with severe therapy-induced cytopeniaTorunn O Apelseth, Tor Hervig, Oystein Bruserud
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|February 4, 2014
Norwegian Red Cross--80 years in service for blood donorsTor Ole Bergan, Tor Hervig, Jerard Seghatchian
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 25, 2013
Blood doping: the flip side of transfusion and transfusion alternativesDaniel Limi Cacic, Tor Hervig, Jerard Seghatchian
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 16, 2010
Current debate on pathogen inactivation of platelet concentrates--to use or not to use?Tor Hervig, Jerard Seghatchian, Torunn Oveland Apelseth
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 25, 2013
[Dietary supplement of iron for iron deficiency]Rune J Ulvik, Rolf Møller, Tor Hervig
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|February 9, 2010
Self-treatment of an ABO-incompatible blood transfusionGuro Kristin Melve, Tor Hervig, Jerard Seghatchian
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 3, 2014
Storage and handling of blood components – perspectivesTor Hervig, Silje Helland Kaada, Jerard Seghatchian
Pageof 12

Showing results (11-20 of 118) with videos related to

Sort By:
Pageof 12
British Journal of Haematology|January 17, 2023
The 'scintilla' starting vaso-occlusion in sickle cell diseaseAndrea Piccin, Ibrahim Magzoub, Tor Hervig
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 8, 2013
Anemia treatment of lymphoproliferative malignancies with erypoiesis: an overview of state of the artDaniel Limi Cacic, Tor Hervig, Jerard Seghatchian
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 26, 2011
Effect of pathogen inactivation on the storage lesion in red cells and platelet concentratesJerard Seghatchian, Tor Hervig, Jeffrey S Putter
Blood Reviews|February 15, 2011
Current practice and future directions for optimization of platelet transfusions in patients with severe therapy-induced cytopeniaTorunn O Apelseth, Tor Hervig, Oystein Bruserud
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|February 4, 2014
Norwegian Red Cross--80 years in service for blood donorsTor Ole Bergan, Tor Hervig, Jerard Seghatchian
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 25, 2013
Blood doping: the flip side of transfusion and transfusion alternativesDaniel Limi Cacic, Tor Hervig, Jerard Seghatchian
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 16, 2010
Current debate on pathogen inactivation of platelet concentrates--to use or not to use?Tor Hervig, Jerard Seghatchian, Torunn Oveland Apelseth
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|April 25, 2013
[Dietary supplement of iron for iron deficiency]Rune J Ulvik, Rolf Møller, Tor Hervig
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|February 9, 2010
Self-treatment of an ABO-incompatible blood transfusionGuro Kristin Melve, Tor Hervig, Jerard Seghatchian
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 3, 2014
Storage and handling of blood components – perspectivesTor Hervig, Silje Helland Kaada, Jerard Seghatchian
Pageof 12